BriaCell Therapeutics Corp. (BCTX) Current Reports & Earnings Releases
| Filed | Form | Items | Filing |
|---|---|---|---|
| 2026-06-26 | 8-K | Reg FD Disclosure, Financial Statements & Exhibits | SEC |
| 2026-06-03 | 8-K | Material Agreement, Unregistered Sales, Other Events, Financial Statements & Exhibits | SEC |
| 2026-03-31 | 8-K | Reg FD Disclosure, Financial Statements & Exhibits | SEC |
| 2026-03-09 | 8-K | Shareholder Vote Results | SEC |
| 2026-02-20 | 8-K | Other Events, Financial Statements & Exhibits | SEC |
| 2026-01-15 | 8-K | Material Agreement, Other Events, Financial Statements & Exhibits | SEC |
| 2025-12-29 | 8-K | Reg FD Disclosure, Financial Statements & Exhibits | SEC |
| 2025-12-01 | 8-K | Reg FD Disclosure, Financial Statements & Exhibits | SEC |
| 2025-08-26 | 8-K | Other Events, Financial Statements & Exhibits | SEC |
| 2025-07-16 | 8-K | Material Agreement, Other Events, Financial Statements & Exhibits | SEC |
| 2025-06-18 | 8-K | Reg FD Disclosure, Financial Statements & Exhibits | SEC |
| 2025-04-28 | 8-K | Material Agreement, Other Events, Financial Statements & Exhibits | SEC |
| 2025-03-12 | 8-K | Reg FD Disclosure, Financial Statements & Exhibits | SEC |
| 2025-02-13 | 8-K | Other Events | SEC |
| 2025-02-06 | 8-K | Shareholder Vote Results | SEC |
| 2025-02-05 | 8-K | Material Agreement, Unregistered Sales, Other Events, Financial Statements & Exhibits | SEC |
| 2025-01-28 | 8-K | Other Events, Financial Statements & Exhibits | SEC |
| 2025-01-03 | 8-K | Other Events, Financial Statements & Exhibits | SEC |
| 2025-01-03 | 8-K | Other Events, Financial Statements & Exhibits | SEC |
| 2024-12-16 | 8-K | Reg FD Disclosure, Financial Statements & Exhibits | SEC |
| 2024-12-13 | 8-K | Material Agreement, Unregistered Sales, Other Events, Financial Statements & Exhibits | SEC |
| 2024-11-25 | 8-K | Officer / Director Changes | SEC |
| 2024-11-01 | 8-K | Reg FD Disclosure, Financial Statements & Exhibits | SEC |
| 2024-10-02 | 8-K | Material Agreement, Other Events, Financial Statements & Exhibits | SEC |
| 2024-10-01 | 8-K | Other Events, Financial Statements & Exhibits | SEC |
| 2024-09-12 | 8-K | Material Agreement, Unregistered Sales, Other Events, Financial Statements & Exhibits | SEC |
| 2024-09-11 | 8-K | Other Events, Financial Statements & Exhibits | SEC |
| 2024-08-23 | 8-K | Listing Notice | SEC |
| 2024-07-18 | 8-K | Reg FD Disclosure, Financial Statements & Exhibits | SEC |
| 2024-07-05 | 8-K | Listing Notice | SEC |
| 2024-06-14 | 8-K | Reg FD Disclosure, Financial Statements & Exhibits | SEC |
| 2024-05-17 | 8-K | Material Agreement, Other Events, Financial Statements & Exhibits | SEC |
| 2024-04-02 | 8-K | Reg FD Disclosure, Financial Statements & Exhibits | SEC |
| 2024-01-31 | 8-K | Shareholder Vote Results | SEC |
Sourced from SEC EDGAR 8-K/6-K filings. 8-K is the current-report form for US domestic issuers (Item 2.02 = earnings release); 6-K is the equivalent for foreign private issuers, including ADRs. Originals live on sec.gov.